You are right only half. But what is the revenue contribution in rm terms towards Supercomal from Edward Lifescience and Ambu.
Scomnet's yearly revenue not even 1%of Edwards revenue, but of course there is room to grow but we must know how much business Edward is giving to Supercomal for d moment.

I found that they don't own all their distribution companies. some 50%, some only 17%. And your calculation have not deducted tax. Directors salary and fees also very high. If they can make SGD8 million consider very good already.

Yes, Jan-Mar is driest season, lowest precipitation. Most rainfall will be in July-Sept yearly which gives higher output. So the weakest quarter yearly coming up today

"definitely" i meant

Correct, to be exact energy sales is 29.7mill. Net profit before interest, tax, depreciation is 26.4mill. Just consider it as 3 months sales n np la. Gross Profit is densely that high, if you go to AGM you will know

No, is the most conservative calculation because of 20 years depreciation for the assets.
You can check last quarter energy sales generated by only 1 turbine ie 3 months sales to do rough estimation.

Expected yearly net profit starting from this year onwards to be at USD70-75million. Cash flow of about USD80 million.
Unprecedented earnings...

Hi Hopeful,
Ambu results are not specific enough.
I meant what are the exact RM sales revenue in scomnet Quarterly/Full yearly report attributed to endoscopes, bronchoscopes etc single use scopes.
Their sales are not 100% from AMBU endoscopes, they got other products as well.
Another want to know is whether each & every unit of endoscopes sold by AMBU manufactured by Supercomal Medical Products S/B? Same goes to Edward Lifescience.

What is the amount of endoscope sales over total revenue?
is Supercommal the only vendor for Ambu & Edward Lifesciences' endoscopes?
Anyone got the data?

KC, what is yr thought on fimacorp? Its EPV and plantatn growth prospect vs kfima?

KC, what is yr thought on fimacorp?
Which has better EPV?